Emergent clinical data, however, indicate that up to 40% of GLP-1-mediated weight loss is associated with reductions in lean body mass (LBM)
This research significantly enhances understanding how spatial conflicts influence the effectiveness of flood risk management and what measures can support the development of more resilient and sustainable spatial structures
The oral capsule format is designed for gastrointestinal pharmacology studies investigating local GI effects (gastric ulcer models, IBD models) and systemic bioavailability via the oral route
We hypothesized that individuals who are using GLP-1 RAs would have lower odds of developing SUDs compared to non-users
A small percentage of weight loss patients have reported minor side-effects such as nausea, diarrhea, or constipation although these symptoms usually lessen over time
Frontiers in Physiology , vol